IRVINE, Calif., March 23, 2017 /PRNewswire/ -- Syneron Medical
Ltd. (NASDAQ: ELOS), a leading global aesthetic device company,
today announced that its Annual Report on Form 20-F, containing
audited consolidated financial statements for the year ended
December 31, 2016, as filed with the
Securities and Exchange Commission on March
23, 2017, is available on its website
(www.syneron.com). Shareholders may receive a hard copy of the
annual report free of charge upon request. This press release is
being issued pursuant to NASDAQ Listing Rule 5250(d)(1)(C).
About Syneron Candela:
Syneron Candela is a
leading global aesthetic device company with a comprehensive
product portfolio and a global distribution footprint. The
Company's technology enables physicians to provide advanced
solutions for a broad range of medical-aesthetic applications
including body contouring, hair removal, wrinkle reduction, tattoo
removal, women's intimate wellness treatments, improving the skin's
appearance through the treatment of superficial benign vascular and
pigmented lesions, and the treatment of acne, leg veins and
cellulite. The Company has a wide portfolio of trusted, leading
products including UltraShape, VelaShape, GentleLase, VBeam
Perfecta, PicoWay, CO2RE, CO2RE Intima, Profound and elōs Plus.
Founded in 2000, the company markets, services and supports its
products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan,
and Hong Kong and distributors
worldwide.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/syneron-medical-ltd-announces-availability-of-its-annual-report-on-form-20-f-through-its-website-300428737.html
SOURCE Syneron Medical Ltd.